Literature DB >> 10375593

Apoptosis in relation to proliferating cell nuclear antigen and Dukes' stage in colorectal adenocarcinoma.

S Evertsson1, Z Bartik, H Zhang, A Jansson, X F Sun.   

Abstract

Colorectal cancer is a disease that is associated with default in the balance of apoptotic regulation. In the present study apoptosis was examined in 158 colorectal adenocarcinomas using the terminal deoxynucleotidyl transferase mediated digoxigenin nick end labeling (TUNEL) method. The median apoptotic index (AI) was 0.95% (range 0-6. 68%). Eighty-two tumours exhibited AI </=0.95% and 76 tumours showed AI >0.95%. We revealed a positive correlation between apoptosis and proliferation determined as the expression of proliferating cell nuclear antigen (PCNA, p=0.002). The frequency of apoptosis increased from Dukes' stage A, B, C to D (p=0.01). No correlations were found between apoptosis and the patients' sex, age, tumour location, growth pattern, differentiation, prognosis, bcl-2, p53 or K-ras. Our findings suggest that we should further investigate the relationship between apoptosis and cellular proliferative activity in colorectal cancer to evaluate whether this might provide additional information in the selection of patients for effective adjuvant therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10375593     DOI: 10.3892/ijo.15.1.53

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

Review 1.  Development and progression of colorectal neoplasia.

Authors:  Upender Manne; Chandrakumar Shanmugam; Venkat R Katkoori; Harvey L Bumpers; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

2.  The correlation between IGF-II and Bcl-2 expression in colorectal adenocarcinoma.

Authors:  Ming-Sheng Zhang; Ai-Hua Hu; Hong Qiu; Hui-Hua Xiong; Yuan Chen
Journal:  Med Oncol       Date:  2011-03-06       Impact factor: 3.064

Review 3.  [Clinical, pathological and molecular prognostic factors in colorectal carcinomas].

Authors:  S E Baldus
Journal:  Pathologe       Date:  2003-01-21       Impact factor: 1.011

4.  Caspase-3 activity, response to chemotherapy and clinical outcome in patients with colon cancer.

Authors:  Javier de Oca; Daniel Azuara; Raquel Sanchez-Santos; Matilde Navarro; Gabriel Capella; Victor Moreno; Anna Sola; Georgina Hotter; Sebastiano Biondo; Alfonso Osorio; Joan Martí-Ragué; Antoni Rafecas
Journal:  Int J Colorectal Dis       Date:  2007-09-04       Impact factor: 2.571

5.  Expression of AEG-1 mRNA and protein in colorectal cancer patients and colon cancer cell lines.

Authors:  Sebastian Gnosa; Yang-Mei Shen; Chao-Jie Wang; Hong Zhang; Johannes Stratmann; Gunnar Arbman; Xiao-Feng Sun
Journal:  J Transl Med       Date:  2012-05-29       Impact factor: 5.531

6.  The role and prognostic value of apoptosis in colorectal carcinoma.

Authors:  Julia Alcaide; Rafael Funez; Antonio Rueda; Elisabeth Perez-Ruiz; Teresa Pereda; Isabel Rodrigo; Rafael Coveñas; Miguel Muñoz; Maximino Redondo
Journal:  BMC Clin Pathol       Date:  2013-10-10

7.  MicroRNA Expression Profile Reveals miR-17-92 and miR-143-145 Cluster in Synchronous Colorectal Cancer.

Authors:  Wen-Jian Meng; Lie Yang; Qin Ma; Hong Zhang; Gunnar Adell; Gunnar Arbman; Zi-Qiang Wang; Yuan Li; Zong-Guang Zhou; Xiao-Feng Sun
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.